To give further insight into the chronology of the loss of CD9 with treatment with GS-168AT2, two groups of animals (three animals per group) xenografted with NCI-H460 tumours as above were treated for 5 days with either vehicle or GS-168AT2, under the same conditions as above. Here, CD9 is linked to neoplasm.